Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
148.38B
Market cap148.38B
Price-Earnings ratio
19.40
Price-Earnings ratio19.40
Dividend yield
6.54%
Dividend yield6.54%
Average volume
36.25M
Average volume36.25M
High today
$26.95
High today$26.95
Low today
$26.01
Low today$26.01
Open price
$26.58
Open price$26.58
Volume
24.44M
Volume24.44M
52 Week high
$28.75
52 Week high$28.75
52 Week low
$21.97
52 Week low$21.97

Stock Snapshot

The current Pfizer(PFE) stock price is $26.09, with a market capitalization of 148.38B. The stock trades at a price-to-earnings (P/E) ratio of 19.40 and offers a dividend yield of 6.5%.

On 2026-05-05, Pfizer(PFE) stock traded between a low of $26.01 and a high of $26.95. Shares are currently priced at $26.09, which is +0.3% above the low and -3.2% below the high.

The Pfizer(PFE)'s current trading volume is 24.44M, compared to an average daily volume of 36.25M.

In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $21.97.

In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $21.97.

PFE News

Sherwood News 4h
Pfizer reports Q1 results above consensus, reaffirms 2026 guidance

Pfizer reports Q1 results above consensus, reaffirms 2026 guidance Pfizer rose in premarket trading after it reported earnings results that beat Wall Street ex...

Pfizer reports Q1 results above consensus, reaffirms 2026 guidance
TipRanks 5h
PFE Earnings: Pfizer Stock Rises on Q1 Beat despite Lower 2026 Sales Outlook

Pfizer’s (PFE) shares rose over 2% early Tuesday after the American pharma giant released first-quarter 2026 earnings results that surpassed the Wall Street con...

The Wall Street Journal 5h
Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

First-quarter revenue rose 5% to $14.45 billion. Wall Street expected $13.84 billion. clodagh kilcoyne / Reuters Pfizer PFE -0.11 %decrease; red down pointing...

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

Analyst ratings

50%

of 30 ratings
Buy
40%
Hold
50%
Sell
10%

More PFE News

CNBC 5h
Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. Pfizer on Tuesday posted first-quarter earnings and revenue that topped...

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth
Nasdaq 6h
Pfizer Q1 26 Earnings Conference Call At 10:00 AM ET

(RTTNews) - Pfizer Inc. (PFE) will host a conference call at 10:00 AM ET on Tuesday, May 5, 2026 ,to discuss Q1 26 earnings results. To access the live webcast...

Pfizer Q1 26 Earnings Conference Call At 10:00 AM ET
Benzinga 24h
Pfizer, Arvinas Win FDA Nod For First-Of-Its-Kind Breast Cancer Therapy

The approval covers estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-), estrogen receptor 1 (ESR1)-mutated advanced or m...

Pfizer, Arvinas Win FDA Nod For First-Of-Its-Kind Breast Cancer Therapy
Benzinga 1d
How To Earn $500 A Month From Pfizer Stock Ahead Of Q1 Earnings

Benzinga Pro puts the consensus estimate for Pfizer's quarterly revenue at $13.8 billion. Pfizer reported $13.71 billion last year. With the recent buzz around...

How To Earn $500 A Month From Pfizer Stock Ahead Of Q1 Earnings
TipRanks 1d
Pfizer Reports Q1 Earnings Tomorrow. What Shareholders Should Expect.

Pharmaceuticals giant Pfizer (PFE) is set to report its Q1 earnings on May 5. The stock is up over 7% in the year-to-date as investors get excited about its dru...

Nasdaq 2d
Pfizer Stock: Still Priced Like It's Dead Money

Key Points Pfizer is facing headwinds today, which is why investors seem to be ignoring the stock. The giant pharmaceutical company is still an industry leade...

Pfizer Stock: Still Priced Like It's Dead Money
Simply Wall St 3d
Does VYNDAMAX Exclusivity To 2031 And ELREXFIO Data Change The Bull Case For Pfizer?

In late April 2026, Pfizer resolved US patent disputes over its cardiomyopathy drug VYNDAMAX by settling with three generic manufacturers, effectively extending...

Does VYNDAMAX Exclusivity To 2031 And ELREXFIO Data Change The Bull Case For Pfizer?

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.